- Report
- January 2025
- 180 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- January 2025
- 183 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- January 2025
- 183 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- November 2024
- 180 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- November 2024
- 180 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- October 2024
- 181 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- September 2024
- 187 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- August 2024
- 186 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- July 2024
- 183 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- June 2024
- 185 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- May 2024
- 184 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- May 2024
- 183 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- April 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- March 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1826EUR$2,000USD£1,550GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1370EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1370EUR$1,500USD£1,162GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1141EUR$1,250USD£969GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1826EUR$2,000USD£1,550GBP

The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more